Synexa Joins CEPI in advancing global epidemic preparedness and response
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
These initiatives aim to improve access to healthcare for rare disease patients
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
The collaboration between CORONA and Ferring will cater to patients across India
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Subscribe To Our Newsletter & Stay Updated